๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Bleomycin: Its utilization in the treatment of head and neck cancer

โœ Scribed by Robert C. Bone; John E. Byfield; Alan P. Feren; Stephen L. Seagren

Book ID
115040607
Publisher
John Wiley and Sons
Year
1979
Tongue
English
Weight
710 KB
Volume
89
Category
Article
ISSN
0023-852X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Dibromodulcitol plus bleomycin compared
Dibromodulcitol plus bleomycin compared with bleomycin alone in head and neck cancer
โœ B. F. Issell; G. Borsos; J. C. D'Aoust; F. Banhidy; S. T. Crooke; S. Eckhardt ๐Ÿ“‚ Article ๐Ÿ“… 1982 ๐Ÿ› Springer ๐ŸŒ English โš– 218 KB

Advanced recurrent squamous cell head and neck cancer patients were prospectively randomized to receive or not receive dibromodulcitol 10 mg/kg PO weekly for 8 consecutive weeks in addition to bleomycin chemotherapy. Patients initially entered in the study received bleomycin 15 mu/m2 three times wee

Chemotherapy of head and neck cancer: Co
Chemotherapy of head and neck cancer: Combination treatment with cyclophosphamide, adriamycin, methotrexate, and bleomycin
โœ Wittes, Robert E. ;Spiro, Ronald H. ;Shah, Jatin ;Gerold, Frank P. ;Koven, Berna ๐Ÿ“‚ Article ๐Ÿ“… 1977 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 470 KB ๐Ÿ‘ 1 views

## Abstract A combination of cyclophosphamide, adriamycin, methotrexate, and bleomycin (CAMB) was explored in patients with advanced, nonresectable epidermoid carcinoma from primary sites in the head and neck, recurrent or persistent after radiation or surgery. Objective regression (greater than 50